MOLECULAR GENETIC ANALYSES

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "MOLECULAR GENETIC ANALYSES"

Transcription

1 Patient data (please fill out clearly in block letters) Family name First name Date of birth Id. No. Day Month Year Age male female Request form MOLECUL GENETIC ANALYSES (DNA Analyses) Client data Physician Center for Human Genetics Ingelheim Konrad-Adenauer-Str Ingelheim, Germany Phone , -203, -224, -165 or -578 Fax or Website: Sample type EDTA blood DNA Amniotic fluid Chorionic villi Umbilical cord blood others, please specify Number of tubes sent Sampling date Indication - Clinical data Please note that detailed pedigree and clinical information is important for interpretation of results. Please provide the following information: Parental consanguinity Patient/proband is affected Family members affected yes yes yes no no no if yes, who Clinical data (medical history, report copies welcome) Ethnic origin Caucasian Middle East Asia Ashkenazi/Jewish French Canadian/Acadian Finnish Other In our lab we offer different testing panels by Next-Generation Sequencing (NGS). The spectrum covered by these panels is being extended constantly. For further information, please contact us ( ). Copyright bioscientia j Reproduction prohibited Declaration of Informed Consent With my signature, I declare that I was briefed on.. (physician) about the nature, importance and implications of the genetic test and that I give my consent to the following genetic analysis and to the collection of the blood or tissue samples needed for this purpose: I consent to the storage, in accordance with legal requirements, of the recorded data in paper and/or electronic form and to their use and/or publication in pseudoanonymized form for scientific purposes for quality assurance. I agree that my test results will not be destroyed after 10 years (as is requested by law) to allow my family access to them in the event of my death. I consent to the results of the tests being made available to the following persons in addition to the doctor who submitted them: I hereby agree to the transfer, in accordance with 950 BGB, of any test material remaining at the end of the analysis to the laboratory that carried out the analysis and I consent to its use for scientific purposes in pseudoanonymized form. I consent to the communication of my data to a medical billing clearing house for invoicing purposes. I am aware that I may withdraw this consent at any time, verbally or in writing, without giving reasons and without this having any adverse consequences for me. Place, date: - Please delete as appropriate - Name of patient / legal representative: Signature of patient / legal representative: This label should be stuck onto the attached copy and kept for your records. DO NOT SEND TO US.

2 Array-CGH (specific form available) NEXT-GENERATION SEQUENCING (NGS) PANELS Eye (retinal) panels Leber congenital amaurosis (LCA) Retinitis pigmentosa, Retinitis pigmentosa, Cone-rod dystrophy Senior-Loken syndrome Deafness panels Deafness, Deafness, Deafness, Usher syndrome, SANDD syndrome Kidney/Liver panels Polycystic kidney diseases (ADPKD/PKD) Nephronophthisis (NPHP)/ -related disorders Senior-Loken syndrome Renal hypo-/dysplasia/agenesis/cakut Renal tubular dysgenesis (RTD) Nephrotic syndrome (SRNS) Focal segmental glomerulosclerosis (FSGS) Hemolytic uremic syndrome (ahus)/ DDD/MPGN Polycystic liver diseases (PCLD) Skeletal/Connective tissue panels Marfan syndrome and related diseases Ehlers-Danlos syndrome Osteogenesis imperfecta Osteopetrosis, Filamin diseases Other ciliopathy panels Bardet-Biedl syndrome/ Joubert syndrome Meckel-Gruber syndrome Jeune syndrome (ATD) Ellis-van-Crefeld syndrome (EVC) Sensenbrenner syndrome (CED) Filamin diseases Primary ciliary dyskinesia (PCD)/ Kartagener syndrome Other NGS-panels Neurofibromatosis (NF) Tuberous Sclerosis (TSC) MODY diabetes All genes analysed by NGS can still be examined by conventional Sanger-sequencing (see below). MOLECUL GENETIC ANALYSES (in alphabetical order) Copyright bioscientia j Reproduction prohibited A Achondrogenesis, Achondroplasia Acromesomelic dysplasia, type Grebe Acromesomelic dysplasia, type Maroteaux Acute lymphoblastic leukemia* (ALL) Acute myeloid leukemia* (AML) ADMCKD (Autosomal dominant medullary cystic kidney disease) ADPKD Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency Adrenoleukodystrophy Afibrinogenemia, congenital* Agammaglobulinemia, * Alagille syndrome Alexander disease* Alkaptonuria* Alpha-1 antitrypsin deficiency Alpha galactosidase A deficiency (Fabry disease) Alpha thalassemia* Alport-like syndrome (Epstein/Fechtner), Alzheimer disease* familial, familial, type 3 Andersen-Tawil syndrome Androgen insensitivity syndrome* Angelman syndrome microsatellite analysis UPD(15)pat sequence analysis UBE3A Angiotensin I converting enzyme Aniridia Anonychia Antley-Bixler syndrome* Apert syndrome (see Craniosynostosis) Apolipoprotein B Apolipoprotein E Apparent mineralcorticoid excess Arginase Argininosuccinate lyase Argininosuccinate synthetase Aristaless-gene-related disorders* NPR2 PKD1, PKD2 CYP21A2 ABCD1 FGA, FGB, FGG BTK JAG1 GFAP HGD SERPINA1 HBA MYH9 COL4A5 COL4A3, COL4A4 APP PSEN1 KCNJ2 UBE3A ACE PAX6 RSPO4 APOB APOE HSD11B2 G1 ASL ASS1 X B C Aromatic L-aminoacid decarboxylase PKD (see polycystisc kidney disease) Arthrogryposis multiplex congenita* Arylsulfatase A Ataxia, 3 Ataxia with isolated Vitamin E Ataxia with oculomotor apraxia 1* Atypical PKU* (Tetrahydropterin, BH4-Mangel) Auditory neuropathy Autoimmune lymphoproliferative syndrome A* Autoimmune polyendocrine syndrome * Azoospermia* DDC TPM2, TNNI2 SA SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 TTPA Bannayan-Riley-Ruvalcaba syndrome* BCR/ABL (chronic myeloid leukemia) Beckwith-Wiedemann syndrome KvDMR1 and H19-DMR microsatellite analysis UPD(11)pat sequence analysis CDKN1C Beta thalassemia* Bloch-Sulzberger syndrome* (Incontinentia pigmenti, IP2) BOR syndrome 1,3 Brachydactyly type C Breast/Ovarian cancer* Brugada syndrome Burkitt lymphoma* Butyrylcholinesterase Byler disease CADASIL Campomelic dysplasia* Canavan syndrome* Carnitine, systemic primary transferase I transferase II Catechol-O methyltransferase activity Ceroid lipofuscinosis, neural (all types) APTX TNFRSF6 AIRE USP9Y BCR/ABL CDKN1C IKBKG BRCA1, BRCA2 SCN5A MYC BCHE ATP8B1 NOTCH3 SOX9 ASPA SLC22A5 CPT1 CPT2 COMT D CHGE syndrome Chloride diarrhea, familial* Chondrodysplasia type Grebe Chorea Huntington* Chronic lymphatic leukemia (CLL) Ciliary dyskinesia, primary CINCA syndrome Cleidocranial dysplasia Clubbing of digits COACH syndrome Coats disease* Cockayne syndrome* Colon carcinoma non polyposis associated, familial (HNPCC)* poliposis coli, familial adenomatous Congenital disorder of glycosylation a* Corneal dystrophy Cornelia-De-Lange syndrome* CORS syndrome Costello syndrome* Coumarin resistance Cowden syndrome* Cranioectodermal dysplasia Craniosynostosis, FGFR associated Crigler-Najjar syndrome Crouzon syndrome (see Craniosynostosis) Cystinosis* Cystinuria* Cystic fibrosis 3 most common mutations with OLA Middle-East-Panel Cystic kidney disease Cytochrom P450 defects CHD7 SLC26A3 HTT IgVH DNAH5 DNAI1 RUNX2 ERCC8, ERCC6 MLH1, MSH2 PMM2 DCN NIPBL HRAS VKORC1 FGFR1, FGFR2, Deafness, 1,2,3 Pendred syndrome Deafness, 1,2,3 Dentato-Rubro-Pallido-Luysiane atrophy* Denys-Drash syndrome Desbuquois syndrome CTNS GJB2/Cx26 GJB6/Cx30 SLC26A4, FOXI1 ATN1 CANT

3 E F G H Diabetes, (MODY) 3 Maturity Onset Diabetes of the Young Diabetes insipidus Diabetes mellitus, neonatal with congenital hypothyroidism Diamond-Blackfan anemia* RPS19 Dihydropteridine reductase QDPR DPD deficiency DPYD (Dihydropyrimidine dehydrogenase deficiency) Dravet syndrome Dysautonomia, familial (Riley-Day syndrome) Dyserythropoietic anemia with thrombocytopenia* Dysfibrinogenemia, congenital 3 Dystonia (DOPA responsive) Dystonia (torsion 1, ) Ehlers-Danlos syndrome 1 Ectodermal dysplasia * EDA Ektrodactyly (EEC syndrome)* TP63 Ellis-van-Creveld syndrome EVC1, EVC2 Epilepsies Epidermolysis bullosa Ewing sarcoma, t(11;22) translocation* EWS Fabry disease Factor II deficiency Factor V Leiden mutation Factor V- and Factor VIII deficiency, combined Factor X deficiency Familial mediterranean fever (FMF) Fanconi anemia* Fatty acid oxidation disorder (acylcarnitine profile)* Feingold syndrome* Fragile X syndrome Fraser syndrome* Frasier syndrome Friedreich ataxia* Fructose intolerance, hereditary Fructose-1,6-bisphosphatase- FSGS 1,3 (fokal segmental glomerulosclerosis) Galactosemia* Gaucher disease* Glaucoma* Glomerulosclerosis, fokal segmental (FSGS) 1,3 Glucocorticoid deficiency Glucose-6-phosphatdehydrogenasedeficiency Glucose transport defect* Glutaric acidemia * Glutathione S-transferase defects* Glycerol kinase Glycogen storage diseases* 1 Granulomatosis, chronic* Greig syndrome Gusher syndrome Haemophilia A* Haemophilia B* Hallervorden-Spatz disease Hemochromatosis Hemolytic uremic syndrome (HUS) 1,2,3 HIV susceptibility* HNF1-b disease (see RCAD) Holocarboxylase synthetase deficiency Holoprosencephaly* Homocystinuria* HPA-1 genotyping* Hydroxymethylbilane synthase* Hyperaldosteronism, familial * Hypercholesterinemia Hypereosinophilic syndrome* Hyperekplexia (KOK disease)* Hyper-IgD syndrome Hyper-IgM syndrome* Hyperinsulinism, congenital* SCN1A IKBKAP GATA1 FGA, FGB, FGG GCH1, TH DYT1 FII FV LMAN1 MEFV MYCN FMR1 FRAS1, FREM2 N ALDOB FBP1 GALT MC2R, MRAP G6PD SLC2A1 GCDH GK GLI3 POU3F4 FVIII PANK2 HFE CCR5, CCR2, CXCL12 HLCS CBS HPA1 HMBS CYP11B1, CYP11B2 FIP1L1, PDGFRA GLRA1 MVK ABCC8, KCNJ11, GLUD1 I J K L M Hyperkalemic periodic paralysis Hyperoxaluria, primary Hyperthyroidism, familial, non autoimmune Hypochondroplasia Hypokalemic periodic paralysis Hypophosphatasia, infantile* Hypophosphatemia* Hypothyroidism Hypoventilation syndrome CACNA1A, ALPL Idiopathic short stature Insulin-like growth factor 1 deficiency (IGF deficiency) Immunodeficiency, severe, combined,, T-cell neg., B-cell pos., NK-cells neg. Ivemark syndrome 2 Jeune syndrome 1,2,3 Kabuki syndrome Kallmann syndrome 1,3 Kartagener syndrome (see ciliary dyskinesia, primary) Kearns-Sayre syndrome* Kell incompatibility* Kniest dysplasia Lafora syndrome Lactose intolerance, congenital Langer, mesomelic dysplasia Laron syndrome Larsen syndrome Lathosterolosis* Leber congenital amaurosis (LCA) 1,2,3 Leber hereditary opticus neuropathy (LHON) LEOPD syndrome Leri-Weil syndrome Lesh-Nyhan syndrome Leukocyte adhesion deficiency FGF23 PHEX IGF1 JAK3 NPHP3 MLL2 MTTL2 KEL EPM2A, NHLRC1 LCT GHR FLNB CHST3 SC5DL mtdna PTPN11 HPRT1 ITGB2 SLC35C1 p53 SCNN1B, SCNN1G Li-Fraumeni syndrome* Liddle syndrome* Lissencephaly* Loeys-Dietz syndrome Long QT syndrome Romano-Ward syndrome 3 Andersen-Tawil syndrome Timothy syndrome Lowe syndrome* Lymphohistiocytosis*, hemophagocytic, familial Lymphoma* Lymphedema * OCRL1 BCL2 FLT4 BCL1 Mantle cell lymphoma* Marfan syndrome FBN1 MASA syndrome* Meckel-Gruber syndrome 1,2,3 Mediterranean fever, familial (FMF) MEFV CMM2, CDKN2A Melanoma* MELAS syndrome* Menkes syndrome* MERRF syndrome* Metaphyseal chondrodysplasia (Schmid type) hot spot analysis complete gene analysis incl. hot spots ATP7A COL10A1 N O Methylentetrahydrofulate reductase Methylmalonic aziduria* Meulengracht syndrome Mikrosatellite analysis (maternal contamination of fetal specimen) Mitochondrial complex II Mitochondrial DNA depletion syndrome* MTHFR MUT SDHA Molybdenum cofactor Morbus Crohn CD15 (CD15 polymorphism) Morbus Fabry Morbus Gaucher* Morbus Gilbert ( promotor, TA insertion) Morbus Krabbe* GALC Morbus Meulengracht Morbus Osler* Morbus Pompe* GAA Morbus Wilson ATP7B MORM syndrome INPP5E Muckle-Wells syndrome Muenke syndrome (see Craniosynostosis) Mucolipidosis* GNPTAB Mucopolysaccharidosis* Multi drug resistance* Multiple exostosis* EXT1, EXT2 Muscular dystrophies Myasthenia syndrome*, CHRNE, CHAT congenital combined with AChR deficiency IFNGR1, IFNGR2 Mycobacteriosis*, familial atypical Myeloproliferative disorders Myoclonic epilepsy severe of infancy Unverricht-Lundborg Myotonia congenita* Myotonic dystrophy Myotubular myopathy,* N-acetyl glutamate synthetase N-acetyltransferase 2 deficiency Nail-Patella syndrome NP syndrome* NDH syndrome Neoplasia, multiple endocrine * A B Nephropathy, familial, juvenile, hyperuricemic Nephronophthisis 1,2,3 Nephrotic syndrome 1,2,3 Netherton syndrome Neurofibromatosis Neuropathies 1,2,3 Neutropenia*, congenital, Nevoid basal cell carcinoma 3 * Nieman-Pick disease* Non small cell lung cancer* Noonan syndrome Norrie syndrome* Obesity Oculocutaneous albinism* A, B Onedine syndrome Ophthalmoplegia* Optic athropy Ornithine transcarbamylase Osteogenesis imperfecta Osteogenesis imperfecta, JAK2 SCN1A CSTB CLCN1 DMPK PROMM MTM1 NAGS NAT2 LXM1B MTATP6 MEN1 SPINK5 NF1 NF2 ELA2 EGFR PTPN11, SOS1 MC4R TYR OCA2 OPA1 OTC

4 P R S Osteopetrosis,* Osteoporosis COL1A1, VDR Otopalatodigital syndrome FLNA (OPD1) (OPD2) Melnick-Needles syndrome (MNS) frontometaphyseal dysplasia (FMD) PAI gene analysis Pancreatitis, hereditary Paramyotonia congenita, of von Eulenberg Parkinson disease* Pelizaeus-Merzbacher disease* Peutz-Jeghers syndrome* Pfeiffer syndrome (see Craniosynostosis) Phenylalanine hydroxylase Pierson syndrome PKD1/TSC 2 microdeletion syndrome Polyposis coli, familial adenomatous (FAP) Polysyndactyly* Polycystic kidney disease 1,2,3 () () Polycystic kidney disease, PAI1 PRSS1, SPINK1, severe infantile, with tuberous sclerosis Pontocellebar hypoplasia Prader-Willi syndrome gene microsatellit analysis UPD(15)mat Primary ciliary dyskinesia Primary hypertrophic Osteoarthropathy (Pachydermoperiostose/Tourraine- Solente-Gole syndrome) Progressive familial intrahepatic cholestasis Propionic acidemia* Protein-C Proteus syndrome* Protoporphyria, erythropoietic* Pseudoachondroplasia* Pyruvate carboxylase Pyruvate dehydrogenase RCAD (Renal Cyst and Diabetes syndrome) Renal agenesis/dysplasia Renal cell carcinoma Renal-Coloboma syndrome Renal cysts Renal-tubular dysgenesia 1,2,3 Retinitis pigmentosa 1,2,3 Retinoblastoma Retinoschisis Rett syndrome Rhesus-(Rh) compatibility* Romano-Ward syndrome 3 Rubinstein-Taybi syndrome* Sandhoff disease Schinzel-Giedeon syndrome Senior-Loken syndrome 1,2,3 Sensenbrenner syndrome Septooptic dysplasia* SESAME syndrome Sialuria* Sickle cell anemia PLP STK11 PAH LAMB2 HOXD13 PKD1 PKD2 PKD1/TSC2 VRK1 DNAH5 DNAI1 PCCA, PCCB PROC FECH COMP PC PDHA1, MET PAX2 RB1 RS1 MECP2 CREBBP HEXB SETBP1 HESX1 KCNJ10 SLC17A5 T U V W X Silver-Rusell syndrome KvDMR1 and H19DMR microsatellite analysis UDP(7)mat Sjögren-Larsson syndrome* Sotos syndrome Spastic paraplegia 3 Spinal bulbar muscular atrophy*, type Kennedy Spinal muscular atrophy (SMA) Spinocerebellar ataxia 3 Spondylocostal dysostosis* Spondyloepiphyseal dysplasia Spondyloepiphyseal dysplasia, Sterility (Congenital aplasia of vas deferens) Stickler syndrome Succinate dehydrogenase Surfacant dysfunction pulmonary 1 pulmonary 3* pulmonary 4* Tay-Sachs disease Jewish sreening complete gene and HEXB genes T-cell receptor-g rearrangement* Thanatophoric dysplasia Thiopurine methyltransferase deficiency Thrombophilia Thrombotic thrombocytopenic purpura (TTP) Thyroid hormone resistance Timothy syndrome TNF receptor associated periodic fever Treacher-Collins- Franceschetti syndrome* Trimethylaminuria* TSC2/PKD1 microdeletion syndrome Tuberous sclerosis Tyrosinemia* ALDH3A2 SMN1 DLL3 SEDL SDHB, SDHD SFTPB ABCA3 CSF2RB, HEXB TPMT MTHFR ADAMTS13 THR-beta CACNA1C TNFRSF1A TCOF1 FMO3 TSC1 TSC2 disease (see ADMCKD) Uniparental disomy of chromosome: 3 2, 4, 6, 7, 11, 13, 14, 15, 16 USH1: FC-/Acadian Panel USH2: FC-/Acadian Panel Very long chain acyl-coa dehydrogenase Vitamin D resistant rachitis* Vitreoretinopathy, familial exsudative* Von Hippel-Lindau syndrome von Willebrand disease* Waardenburg syndrome 2,3 Warfarin or Coumarin sensitivity* Weaver syndrome Werner syndrome Wilms tumor Wiskott-Aldrich syndrome* Wolfram syndrome Xanthinuria hydrocephalus* lymphproliferative syndrome* sideroblastic anemia* ACADVL TSPAN12, VHL VWF VKORC1 RECQL2 WAS CISD2 XDH SH2D1A ALAS2 Others sideroblastic anemia and Ataxia* ABCB

5 MOLECUL GENETIC ANALYSES (by disease groups) Copyright bioscientia j Reproduction prohibited Blood disorders Afibrinogenemia, congenital* Alpha thalassemia* Beta thalassemia* Diamond-Blackfan anemia* Dyserythropoietic anemia with thrombocytopenia* Dysfibrinogenemia, congenital 3 Factor II deficiency Factor V-Leiden mutation Factor V- and Factor VIII deficiency, combined Factor X deficiency Haemophilia A* Haemophilia B* HPA-1-genotyping* Kell incompatibility* Neutropenia*, congenital, PAI gene analysis Rhesus (Rh) incompatibility* Sickle cell anemia Thrombophilia Thrombotic thrombocytopenic purpura (TTP) von Willebrand disease* Warfarin or Coumarin sensitivity* Wiskott-Aldrich syndrome* sideroblastic anemia* sideroblastic anemia and Ataxia* Cancer/Leukemia/Tumor Acute lymphoblastic leukemia* (ALL) Acute myeloid leukemia* (AML) Bannayan-Riley- Ruvalcaba syndrome* BCR/ABL (chronic myeloid leukemia) Breast/Ovarian cancer* Burkitt lymphoma* Chronic lymphatic leukemia (CLL)* Colon carcinoma non polyposis associated, familial (HNPCC)* poliposis coli, familial adenomatous Cowden syndrome* Ewing sarcoma, t(11;22) translocation* Fanconi anemia* Li-Fraumeni syndrome* Lymphoma* Mantle cell lymphoma* Melanoma* Myeloproliferative disorder Neoplasia, multiple endocrine * A B Neurofibromatosis Nevoid basal cell carcinoma 3 * Non small cell lung cancer* Peutz-Jeghers syndrome* Proteus syndrome* Renal cell carcinoma Retinoblastoma Tuberous sclerosis Von Hippel-Lindau syndrome Wilms tumor lymphoproliferative syndrome* FGA, FGB, FGG HBA RPS19 GATA1 FGA, FGB,FGG FII FV LMAN1 FVIII HPA1 KEL ELA2 PAI1 METHFR ADAMTS13 VWF VKORC1 WAS ALAS2 ABCB7 BCR/ABL BRCA1, BRCA2 MYC IgVH MLH1, MSH2 EWS p53 BCL2 BCL1 CMM2, CDKN2A JAK2 MEN1 NF1 NF2 EGFR STK11 MET RB1 TSC1 TSC2 VHL SH2D1A Cardiac disorders Angiotensin I converting enzyme ACE Brugada syndrome SCN5A Long QT syndrome Romano-Ward syndrome 3 Andersen-Tawil syndrome Timothy syndrome Chromosome instability Fanconi anemia* Connective tissue disorders Alpha-1 antitrypsin deficiency Ehlers-Danlos syndrome 1 Surfacant dysfunction pulmonary 1 pulmonary 3* pulmonary 4* Deafness Auditory neuropathy BOR syndrome1,3 Gusher syndrome SANDD syndrome SESAME syndrome Deafness, 1,2,3 Pendred syndrome Deafness, 1,2,3 Waardenburg syndrome 2,3 Dementia Alzheimer disease* familial, familial, type 3 Dentato-Rubro-Pallido- Luysiane atrophy* Endocrinology Androgen insensivity syndrome* Apparent mineralcorticoid excess Diabetes, (MODY) 3 Maturity Onset Diabetes of the Young Diabetes insipidus Diabetes mellitus, neonatal with congenital hypothyreodism Glucocorticoid deficiency Hyperinsulinism, congenital* Hyperthyroidsm, familial, non autoimmune Hypothyroidsm Insulin like growth factor 1 deficiency (IGF deficiency) Kallmann syndrome 1,3 Laron syndrome Lathosterolosis* Liddle syndrome NDH syndrome Thyroid hormone resistance Vitamin D resistent rachitis* Wolfram syndrome Epigenetic disorders Angelman syndrome microsatellite analysis UPD(15)pat sequence analysis UBE3A Beckwith-Wiedemann syndrome KvDMR1 and H19-DMR microsatellite analysis UPD(11)pat sequence analysis CDKN1C SERPINA1 SFTPB ABCA3 CSF2RB POU3F4 CACNA1D KCNJ10 GJB2/Cx26 GJB6/Cx30 SLC26A4, FOXI1 APP PSEN1 ATN1 HSD11B2 MC2R, MRAP ABCC8, KCNJ11, GLUD1 IGF1 GHR SC5DL SCNN1B, SCNN1G THR-beta CISD2 UBE3A CDKN1C Prader-Willi syndrome gene microsatellit analysis UPD(15)mat Silver-Rusell syndrome KvDMR1 and H19DMR microsatellite analysis UDP(7)mat Uniparental disomy of chromosome: 3 2, 4, 6, 7, 11, 13, 14, 15, 16 Epilepsy Aristaless-gene-related disorders* X Epilepsies Lafora syndrome EPM2A, NHLRC1 Myoclonic epilepsy severe, of infancy SCN1A Unverricht-Lundborg CSTB Eye (retinal) disorders Aniridia Coats disease* Congenital stationary night blindness Corneal dystrophy Glaukoma* Leber congenital amaurosis (LCA) 1,2,3 Leber hereditary optic neuropathy (LHON) Lowe syndrome* Norrie syndrome* Oculocutaneous albinism* A, B Ophthalmoplegia* Retinitis pigmentosa 1,2,3 Retinoschisis (see Usher syndrome) Vitreoretinopathy, familial exsudative* Gastroenterologic disorders Alagille syndrome Byler disease Chloride diarrhea, familial* Crigler-Najjar syndrome Cystic fibrosis 3 most common mutations with OLA Middle-East-Panel Morbus Crohn (CD15 polymorphism) Morbus Gilbert Pancreatitis, hereditary Peutz-Jeghers syndrome* Polyposis coli, familial adenomatous (FAP) Progressive familial intrahepativ Cholestasis Immune system disorders Agammaglobulinemia, * Autoimmune lymphoproliferative syndrome * Autoimmune polyendocrine syndrome A* Granulomatosis, chronic* Hypereosinophilic syndrome* Hyper-IgD syndrome Hyper-IgM syndrome* Immunodeficiency, severe, combined;, T-cell neg., B-cell pos., NK-cells neg. Leukocyte adhesion deficiency PAX6 DCN mtdna OCRL1 TYP OCA2 RS1 TSPAN12. JAG1 ATP8B1 SLC26A3 CD15 PRSS1, SPINK1, STK11 BTK TNFRSF6 AIRE FIP1L1, PDGFRA MVK JAK3 ITGB2 SLC35C

6 Lymphohistiocytosis*, hemophagocytic, familial Lymphoma* Muckle-Wells syndrome Neutropenia*, congenital, T-cell receptor-g rearrangement* Infection HIV susceptibility* Mycobacteriosis*, familial atypical Infertility Azoospermia* Cystic fibrosis 3 most common mutations with OLA Middle-East-Panel Kallmann syndrome 1,3 Kartagener syndrome (see primary ciliary dyskinesia) Primary ciliary dyskinesia Sterility (congenital aplasia of vas deferens) Inflammation CINCA syndrome Familial mediterranean fever (FMF) Hyper-IgD syndrome TNF receptor associated periodic fever Kidney disorders ADMCKD ( medullary cystic kidney disease) ADPKD Alport-like syndrome (Epstein/Fechtner), PKD BOR syndrome 1,3 Cystinosis* Denys-Drash syndrome Diabetes insipidus Frasier syndrome Glomerulosclerosis, fokal segmental (FSGS) 1,3 Hemolytic uremic syndrome (HUS) 1,3 HNF1-b disease (see RCAD) Hyperoxaluria, primary Ivemark syndrome 2 Meckel-Gruber syndrome 1,2,3 Morbus Fabry Nail-Patella syndrome Nephropathy, familial, juvenile hyperuricemic Nephronophthisis 1,2,3 Nephrotic syndrome 1,2,3 PKD1/TSC 2 microdeletion syndrome Polycystic kidney disease 1,2,3 () () Polycystic kidney disease, severe infantile, with tuberous sclerosis RCAD (Renal Cysts and Diabetes syndrome) Renal agenesis/dysplasia Renal-Coloboma syndrome Renal cysts Renal-tubular dysgenesis 1,2,3 Senior-Loken syndrome 1,2,3 Sialuria* ELA2 CCR5, CCR2, CXCL12 IFNGR1, INFGR2 USP9Y DNAH5 DNAI1 MEFV MVK TNFRSF1A PKD1, PKD2 MYH9 COL4A5 COL4A3, COL4A4 CTNS NPHP3 LMX1B PKD1 PKD2 PKD1/TSC2, PAX2 SLC17A5 Tuberous sclerosis TSC2/PKD1 microdeletion syndrome disease (see ADMCKD) Makrosomia/Giantism Beckwith-Wiedemann syndrome KvDMR1 and H19-DMR microsatellite analysis UPD(11)pat sequence analysis CDKN1C Sotos syndrome Weaver syndrome Malformation syndromes Alagille syndrome Antley-Bixler syndrome* BOR syndrome 1,3 CHGE syndrome COACH syndrome Cornelia-De-Lange syndrome* CORS syndrome Costello syndrome* Denys-Drash syndrome Ellis-van-Creveld syndrome Feingold syndrome* Greig syndrome Ivemark syndrome 2 Jeune syndrome 1,2,3 LEOPD syndrome Meckel-Gruber syndrome 1,2,3 MORM syndrome Schinzel-Giedeon syndrome Mental retardation Alexander disease* Angelman syndrome microsatellite analysis UPD(15)pat sequence analysis UBE3A Antley-Bixler syndrome* Aristaless-gene-related disorders* Canavan syndrome* Fragile X syndrome Fraser syndrome* Holoprosencephaly* Kabuki syndrome Lissencephaly* Rett syndrome Metabolic disorders Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency Alkaptonuria* Alpha galactosidase deficiency (Morbus Fabry) Apolipoprotein B Apolipoprotein E Arginase Argininosuccinate lyase Argininosuccinate synthetase Aromatic L-aminoacid decarboxylase Atypical PKU* (Tetrahydropterin, BH4 deficiency) Butyrylcholinesterase Carnitine, systemic primary transferase I transferase II Catechol-O methyltransferase activity Congenital disorder of glycosylation a* TSC1 TSC2 CDKN1C JAG1 CHD7 NIPBL HRAS EVC1, EVC2 MYCN GLI3 NPHP3 PTPN11 INPP5E SETBP1 GFAP UBE3A X ASPA FMR1 FRAS1, FREM2 MLL2 MECP2 CYP21A2 HGD APOB APOE G1 ASL ASS1 DDC BCHE SLC22A5 CPT1 CPT2 COMT PMM2 Dihydropteridine reductase QDPR deficiency DPD deficiency DPYD (Dihydropyrimidindehydrogenase deficiency) Fatty acid oxidation disorder (Acylcarnitine profile)* Fructose intolerance, hereditary Fructose-1,6-bisphosphatase Glucose-6 phosphat dehydrogenase deficiency Glucose transport defect* Glutaric acidemia * Glutathione S-transferase defects* Glycerol kinase Holocarboxylase synthetase Homocystinuria* Hydroxymethylbilane synthase* Hyperaldosteronism, familial * Hypercholesterinemia Lactose intolerance, congenital Methylentetrahydrofulate reductase Methylmalonic aciduria* Meulengracht syndrome Molybdenum cofactor Morbus Gaucher* Morbus Gilbert (promotor, TA insertion) Morbus Krabbe* Morbus Meulengracht Morbus Osler* N-acetyl glutamate synthetase Obesity Ornithine transcarbamylase Phenylalanine hydroxylase Propionic acidemia* Protoporphyria, erythropoietic* Pyruvate carboxylase Pyruvate dehydrogenase Sialuria* Succinate dehydrogenase Thiopurine methyltransferase Trimethylaminuria* Tyrosinemia* Very long chain acyl-coa dehydrogenase Xanthinuria Mitochondriopathies Kearns-Sayre syndrome* Leber hereditary opticus neuropathy (LHON) MELAS syndrome* MERRF syndrome* Mitochondrial complex II Mitochondrial DNA depletion syndrome* Neuromuscular disorders Muscular dystrophies Myotonia congenita* Myotonic dystrophy Myotubular myopathy,* Paramyotonia congenita, of von Eulenberg Neurology/Neuropathies Ataxia, 3 Ataxia with isolated Vitamin E Ataxia with oculomotor apraxia 1* Chorea Huntington* Dentato-Rubro-Pallido- Luysiane atrophy* ALDOB FMP1 G6PD SLC2A1 GCDH GK HLCS CBS HMBS CYP11B1, CYP11B2 LCT MTHFR MUT GALC NAGS MC4R OTC PAH PCCA, PCCB FECH PC PDHA1 SLC17A5 SDHB, SDHD TPMT FMO3 ACADVL XDH MTTL2 mtdna SDHA CLCN1 DMPK PROMM MTM1 SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 TPPA APTX HTT ATN

7 Dysautonomia, familial (Riley-Day syndrome) Dystonia (DOPA responsive) Dystonia (torsion 1, ) Friedreich ataxia* Hallervorden-Spatz disease Hyperekplexia (KOK disease)* Hyperkalemic periodic paralysis Hypokalemic periodic paralysis Hypoventilation syndrome Lafora syndrome Lesh-Nyhan syndrome MASA syndrome* Menkes syndrome* Myasthenic syndrome*, congenital combined with AChR deficiency Myoklonic epilepsy severe of infancy Unverricht-Lundborg NP syndrome* Neuropathies 1,2,3 Onedine syndrome Parkinson disease* Pelizaeus-Merzbacher disease* Pontocellebar hypoplasia Rett syndrome Spastic paraplegies 3 Spinal bulbar muscular atrophy*, type Kennedy Spinal muscular atrophy (SMA) Spinocerebellar ataxies 3 hydrocephalus* Pharmacogenetics Short stature Cytochrome P450 defects DPD deficiency DPYD (Dihydropyrimidindehydrogenase deficiency) Multi drug resistance* N-acetyltransferase 2 deficiency NAT2 Cockayne syndrome* Costello syndrome* Idiopathic short stature Insulin like growth factor 1 deficiency (IGF deficiency) Langer, mesomelic dysplasia Laron syndrome Leri-Weill syndrome Noonan syndrome Silver-Rusell syndrome KvDMR1 and H19DMR microsatellite analysis UDP(7)mat Skeletal disorders Achondrogenesis Achondroplasia Acromesomelic dysplasia, type Grebe Acromesomelic dysplasia, NPR2 type Maroteaux Apert syndrome (see Craniosynostosis) Arthrogryposis multiplex TPM2, TNNI2 congenita* Brachydactyly type C Campomelic dysplasia* SOX9 Chondrodysplasia, type Grebe Cleidocranial dysplasia RUNX2 Clubbing of digits Cranioectodermal dysplasia Craniosynostosis, FGFR1, FGFR2, FGFR associated Crouzon syndrome (see Craniosynostosis) Cystinuria* Desbuquois syndrome Ektrodactyly (EEC syndrome)* Hypochondroplasia Hypophosphatasia, infantile* IKBKAP GCH1, TH DYT1 N PANK2 GLRA1 CACNA1A, EPM2A, NHLRC1 HPRT1 ATP7A CHRNE, CHAT SCN11A CSTB MTATP6 PLP VRK1 MECP2 SMN1 ERCC8, ERCC6 HRAS IGF1 GHR PTPN11, SOS1 CANT1 TP63 ALPL Hypophosphatemia* Kniest dysplasia Langer, mesomelic dysplasia Larsen syndrome Leri-Weill syndrome Loeys-Dietz syndrome Marfan syndrome Metaphyseal Chondrodysplasia (type Schmid) hot spot analysis complete gene analysis incl. hot spots Multiple exostosis* Nail-Patella syndrome Osteogenesis imperfecta Osteogenesis imperfecta, Osteopetrose,* Osteoporosis Otopalatodigital syndrome (OPD1) (OPD2) Melnick-Needles syndrome (MNS) frontometaphyseal dysplasia (FMD) Pfeiffer syndrome (see Craniosynostosis) Polysyndactyly* Pseudoachondroplasia* Rubinstein-Taybi syndrome* Sensenbrenner syndrome Spondylocostal dysostosis* Spondyloepiphyseal dysplasia Spondyloepiphyseal dysplasia, Stickler-syndrome Thanatophoric dysplasia Treacher-Collins- Franceschetti syndrome* Skin and nail disorders Anonychia Bloch-Sulzberger syndrome* (Incontinentia pigmenti, IP2) Ectodermal dysplasia * Epidermolysis bullosa Netherton syndrome Neurofibromatosis Primary hypertrophic Osteoarthropathy (Pachydermoperiostose/Tourraine- Solente-Gole syndrome) Sjögren-Larsson syndrome* Werner syndrome Storage disorders Arylsulfatase A Ceroid lipofuscinosis, neural (all types) Fabry disease Gaucher disease* Glycogen storage diseases* 1 Hemochromatosis Hallervorden-Spatz disease Morbus Krabbe* Morbus Pompe* Morbus Wilson Mucolipidosis* Mucopolysaccharidosis* Nieman-Pick disease* Sandhoff disease Tay-Sachs disease Jewish screening complete gene and HEXB genes Very long chain acyl-coa dehydrogenase FGF23 PHEX FLNB CHST3 FBN1 COL10A1 EXT1, EXT2 LMX1B COL1A1, VDR FLNA HOXD13 COMP CREBBP DLL3 COL2A2 SEDL COL2A2 TCOF1 RSPO4 IKBKG EDA SPINK5 NF1 NF2 ALDH3A2 RECQL2 SA HFE PANK2 GAA ATP7B GNPTAB HEXB, HEXB ACADVL Usher syndrome USH1: FC-/Acadian Panel USH2: FC-/Acadian Panel Vasculopathies CADASIL Lymphedema * 1 We offer molecular testing for all genes known for this disease. In some cases, specific genotype - phenotype correlations exist that allow for targeted testing. Please contact us. 2 We offer linkage analysis where applicable (e. g., samples available from several family members, parental consanguinity) for prioritization of genes to be tested. 3 Stepwise analysis NOTCH3 FLT4 *Analyses are carried out in collaborating certified labs

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

Lab Prior Authorization

Lab Prior Authorization Lab Prior Authorization On July 22, 2015, BlueCross BlueShield of South Carolina announced that it will partner with Avalon Healthcare Solutions (Avalon) to administer a comprehensive suite of laboratory

More information

IN-VITRO FERTILIZATION WITH DONATED OOCYTES COMPREHENSIVE HISTORY OF RECIPIENT COUPLE (HUSBAND)

IN-VITRO FERTILIZATION WITH DONATED OOCYTES COMPREHENSIVE HISTORY OF RECIPIENT COUPLE (HUSBAND) Personal History Name Date of Birth Home Address Home Phone Work Phone Type of Employment Social Security # Medical Insurance Marital Status Religion Highest education degree (high school, college, graduate

More information

Patterns of Single-Gene Inheritance Cont.

Patterns of Single-Gene Inheritance Cont. Genetic Basis of Disease Patterns of Single-Gene Inheritance Cont. Traditional Mechanisms Chromosomal disorders Single-gene gene disorders Polygenic/multifactorial disorders Novel mechanisms Imprinting

More information

Results for Trendy. Explanation of Results

Results for Trendy. Explanation of Results Canine HealthCheck Results for Trendy Trendy's genetic health profile: Trendy's appearance profile: Trendy is not at-risk for any of the diseases tested Trendy is a Female Trendy is not a carrier for any

More information

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY

UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY GNA FOP Familial Adenomatous Polyposis Beckwith-Wiedemann Syndrome Methylation and high resolution copy number analysis of 11p15.5 with automatic reflex to CDKN1C if negative Methylation analysis of 11p15.5

More information

Referring Physician Information Name: (Last, First, Middle):

Referring Physician Information Name: (Last, First, Middle): Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background

More information

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Farrah Farrah's demographic profile: Call Name: Farrah Registered Name: Amber Bear's She's All That Breed: Collie Sex: Female Age: 1 Owner: Registration #: DN44645703 Microchip/Tattoo:

More information

PATIENT EDUCATION. carrier screening INFORMATION

PATIENT EDUCATION. carrier screening INFORMATION PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your

More information

BMS 6204 MEDICAL BIOCHEMISTRY & GENETICS SPRING 2010

BMS 6204 MEDICAL BIOCHEMISTRY & GENETICS SPRING 2010 Week Date Cases Topic Subtopic/Class Activity Readings Jan 4th Course Introduction 1.1 Discussion of course organization, lecture format, quizzes, exams Unit I: Genetic Diseases: Structure and Function

More information

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar Link full download:https://getbooksolutions.com/download/test-bank-for-robbinsand-cotran-pathologic-basis-of-disease-9th-edition-by-kumar Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Clinical Cancer Genetics

Clinical Cancer Genetics Clinical Cancer Genetics Lisen Axell, MS, CGC University of Colorado Cancer Center Individuals with cancer Making surgical decisions (lump vs. mast) Making treatment decisions (XRT) Concerns for additional

More information

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors

More information

Positive Newborn Screens: What do you do next?

Positive Newborn Screens: What do you do next? Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric

More information

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. SAPLE REPORT CARRIER STATUS DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Asian ORDERING HEALTHCARE PROFESSIONAL

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions on Blood/Saliva NF1- only NGS testing and copy number analysis for

More information

Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD. Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No

Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD. Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No Georgia Department of Human Services BIRTH FAMILY BACKGROUND INFORMATION FOR CHILD Name of Child Date of Birth Sex Race Hispanic Ethnicity Yes No Legal County (DHS Child) Resident County (Non-DHS Child)

More information

Genetic and Genomic Testing (Disease Specific) MPM 7.1

Genetic and Genomic Testing (Disease Specific) MPM 7.1 Disclaimer Page 1 of 25 Refer to the member s specific benefit plan and Schedule of Benefits to determine coverage. This may not be a benefit on all plans or the plan may have broader or more limited benefits

More information

Quick Guide To Genetic Testing

Quick Guide To Genetic Testing Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing Panel** 1101 81407 8 weeks $2,500

More information

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4

More information

Human inherited diseases

Human inherited diseases Human inherited diseases A genetic disorder that is caused by abnormality in an individual's DNA. Abnormalities can range from small mutation in a single gene to the addition or subtraction of a whole

More information

Sequencing in Newborn Screening Introduction and Background

Sequencing in Newborn Screening Introduction and Background Sequencing in Newborn Screening Introduction and Background Suzanne Cordovado, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Centers for Disease Control and Prevention

More information

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate MALATTIA PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid

More information

MEDICAL GENETICS CLINICAL CARE ROTATION

MEDICAL GENETICS CLINICAL CARE ROTATION Medical Genetics Clinical Care Rotation 1 MEDICAL GENETICS CLINICAL CARE ROTATION Overview: The Medical Genetics Clinical Care Rotation (MGC) is the backbone of the clinical genetics experience for the

More information

Preimplantation Genetic Diagnosis in Assisted Reproduction

Preimplantation Genetic Diagnosis in Assisted Reproduction I National Medical Policy Subject: Policy Number: Preimplantation Genetic Diagnosis in Assisted Reproduction NMP245 Effective Date*: October 2005 Updated: September 2017 This National Medical Policy is

More information

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

New York Deaf-Blind Collaborative Referring a Child

New York Deaf-Blind Collaborative Referring a Child New York Deaf-Blind Collaborative Referring a Child NYDBC Overview The New York Deaf-Blind Collaborative (NYDBC) is statewide grant that provides technical assistance to improve services for children and

More information

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate DISEASE NAME PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid dehydrogenase X

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Cancer Susceptibility Panels Using Next Generation File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_cancer_susceptibility_panels_using_next_generation_sequencing

More information

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Carrier Screening and Diagnostic Testing for the Ashkenazi Jewish Population Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION Our Science. Your Care. An extensive

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING

CYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING INTRODUCTION The Cytogenetics Laboratory offers a comprehensive array of chromosome investigations for cancers, constitutional abnormalities, and prenatal and postnatal diagnosis. Analyses are performed

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation

More information

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other Requisition Form 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax: 773.702.9130 ucgslabs@genetics.uchicago.edu dnatesting.uchicago.edu CLIA#:

More information

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy

More information

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic

More information

AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS

AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS AMERICAN BOARD OF MEDICAL GENETICS AND GENOMICS Logbook Guidelines for Certification in Clinical Genetics and Genomics for the 2017 Examination as of 10/5/2015 Purpose: The purpose of the logbook is to

More information

Usher Syndrome: Why a definite diagnosis matters

Usher Syndrome: Why a definite diagnosis matters Usher Syndrome: Why a definite diagnosis matters Margaret Kenna, MD, MPH Katherine Lafferty, MS, CGC Heidi Rehm, PhD Anne Fulton, MD Boston Children s Hospital Harvard Medical School Harvard Medical School

More information

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

Applications of Cord Blood Stem Cells

Applications of Cord Blood Stem Cells Applications of Cord Blood Stem Cells over 360 families have used their banked cord blood in transplant or regenerative medicine research. 1 88 ViaCord has released over 360 units for transplant or infusion

More information

Prices listed correspond to institutional rates only; please contact the lab for insurance rates.

Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Prices listed correspond to institutional rates only; please contact the lab for insurance rates. Genetic Test Neurofibromatosis Type 1 - NF1 and Legius syndrome SPRED1 $1400 (NF1/SPRED1 negative) 81408,

More information

Dear Chairmen Hatch and Brady, and Members of the Tax Cuts and Jobs Act Conference Committee:

Dear Chairmen Hatch and Brady, and Members of the Tax Cuts and Jobs Act Conference Committee: December 7, 2017 The Honorable Orrin Hatch, Chairman U.S. Senate Committee on Finance 219 Dirksen Senate Office Building Washington, D.C. 20510 The Honorable Kevin Brady, Chairman U.S. House Committee

More information

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory

Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory Assessing the follow-up of BART hemoglobin reported by the Wisconsin Newborn Screening Laboratory Bao Yang MPH Candidate Background The Wisconsin Newborn Screening (NBS) Laboratory screens 70,000 babies

More information

TUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea

TUMOR-SUPPRESSOR GENES. Molecular Oncology Michael Lea TUMOR-SUPPRESSOR GENES Molecular Oncology 2011 Michael Lea TUMOR-SUPPRESSOR GENES - Lecture Outline 1. Summary of tumor suppressor genes 2. P53 3. Rb 4. BRCA1 and 2 5. APC and DCC 6. PTEN and PPA2 7. LKB1

More information

The laboratory investigation of lactic acidaemia. J Bonham/T Laing

The laboratory investigation of lactic acidaemia. J Bonham/T Laing The laboratory investigation of lactic acidaemia J Bonham/T Laing Reference range Typical ranges for blood lactate are: Newborn 0.3-2.2 mmol/l Nielsen J et al1 1994 1-12mo 0.9-1.8 mmol/l Bonnefont et al

More information

Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis

Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis Medical Coverage Policy Effective Date... 1/15/2018 Next Review Date... 8/15/2018 Coverage Policy Number... 0514 Genetic Testing for Reproductive Carrier Screening and Prenatal Diagnosis Table of Contents

More information

Module 5 Gene Mutations

Module 5 Gene Mutations Module 5 Gene Mutations Gene a finite segment of DNA specified by an exact sequence of bases. Humans have ~0.5X10 5 genes per haploid set of chromosomes. DNA Structure Human Chromosomes Cel l Cycle Prophase

More information

NEONATAL MUSCULAR HYPOTONIA

NEONATAL MUSCULAR HYPOTONIA NEONATAL MUSCULAR HYPOTONIA Differential Diagnosis Systemic causes of neonatal hypotonia should be identified rapidly as they are usually transient if treated appropriately. Major differential diagnoses

More information

LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM

LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM Inderneel Sahai, MD, FACMG Newborn Screening and Genetic Testing Symposium Oct 2014

More information

Pediatric metabolic bone diseases

Pediatric metabolic bone diseases Pediatric metabolic bone diseases Classification and overview of clinical and radiological findings M. Mearadji International Foundation for Pediatric Imaging Aid www.ifpia.com Introduction Metabolic bone

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association General Approach to Evaluating Page 1 of 28 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: General Approach to Evaluating the Utility of Genetic Panels Professional

More information

Summary of disease expertise recorded via RD-ACTION Matchmaker under each Thematic Grouping and EURORDIS Members Thematic Grouping

Summary of disease expertise recorded via RD-ACTION Matchmaker under each Thematic Grouping and EURORDIS Members Thematic Grouping Thematic Grouping Reported expertise of those completing the matchmaker under each heading EURORDIS Member perspectives on Grouping RD Thematically Rare Bone Achondroplasia/Hypochondroplasia Amelia skeletal

More information

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 131 disease or trait variations are found in this genome Report Date: August 2, 215 Software Annotation Version: 8 Genome Summary Name: Greg Mendel Genome ID: genome_greg_mendel_dad Sequencing Provider: 23andMe Sequencing Type: Genotyping SNP Array Sequencing

More information

Committee for Orphan Medicinal Products (COMP)

Committee for Orphan Medicinal Products (COMP) 19 December 2014 EMA/COMP/782108/2014 Procedure Management and Business Support Division Committee for Orphan Medicinal Products (COMP) Agenda of the 7-9 January 2015 Chair Bruno Sepodes, Vice-Chair Lesley

More information

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.

Division of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition. Page 1 of 8 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 PATIENT

More information

NextStep Carrier Screening

NextStep Carrier Screening NextStep Carrier Screening What Is Carrier Screening? Certain genetic disorders occur more frequently in the general population, regardless of ethnic background. Carrier screening to determine if you and

More information

11/14/2013. Progressive Eye Conditions. Agenda. Review from Sessions 1 and 2 Session 1 Review of Eye Conditions. Objectives

11/14/2013. Progressive Eye Conditions. Agenda. Review from Sessions 1 and 2 Session 1 Review of Eye Conditions. Objectives 1 Progressive Eye Conditions Agenda 2:00 Introductions and Reconnect FIMC-VI Webinar Series Eye Conditions and Impact on Learning Session #3 of 3 November 13, 2013 Kay Ratzlaff Florida Instructional Materials

More information

Articles Clinical Approach to Genetic Cardiomyopathy in Children Abstract

Articles Clinical Approach to Genetic Cardiomyopathy in Children Abstract (Circulation. 1996;94:2021-2038.) 1996 American Heart Association, Inc. Articles Clinical Approach to Genetic Cardiomyopathy in Children Marcy L. Schwartz, MD; Gerald F. Cox, MD, PhD; Angela E. Lin, MD;

More information

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing

More information

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD April 24, 2017 SAP 2017 Buenos Aires Genetic disorders are rare why

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Page 1 of 35 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Genetic Cancer Susceptibility

More information

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation:

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation: Genetics of Pancreatic Cancer October 6, 2016 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only: 1-408-435-7088

More information

September 14, The Honorable Orrin Hatch, Chairman U.S. Senate Committee on Finance 219 Dirksen Senate Office Building Washington, D.C.

September 14, The Honorable Orrin Hatch, Chairman U.S. Senate Committee on Finance 219 Dirksen Senate Office Building Washington, D.C. September 14, 2017 The Honorable Orrin Hatch, Chairman U.S. Senate Committee on Finance 219 Dirksen Senate Office Building Washington, D.C. 20510 The Honorable Kevin Brady, Chairman U.S. House Committee

More information

Department of Aging and Disability Services Approved Diagnostic Codes for Persons with Related Conditions

Department of Aging and Disability Services Approved Diagnostic Codes for Persons with Related Conditions Department of Aging and Disability Services Approved Diagnostic Codes for Persons with Related Conditions The following diagnostic codes are found in the International Classification of Diseases, Ninth

More information

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 152 disease or trait variations are found in this genome

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 152 disease or trait variations are found in this genome Report Date: August 19, 2015 Software Annotation Version: 8 Genome Summary Name: EUR NA12877 Father Genome ID: NA12877-200-37-ASM Sequencing Provider: Complete Genomics Sequencing Type: Whole Genome Sequencing

More information

Update on the Genetics of Ataxia. Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic

Update on the Genetics of Ataxia. Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic Update on the Genetics of Ataxia Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic Outline Definitions Review of genetics Autosomal Dominant cerebellar ataxias Autosomal Recessive cerebellar

More information

Allied and Therapeutic Extender Benefit

Allied and Therapeutic Extender Benefit Allied and Therapeutic Extender Benefit 2012 Allied and Therapeutic Extender Benefit The Allied and Therapeutic Extender Benefit is available on the Executive and Comprehensive Plans only. Overview This

More information

Prevalence and incidence of rare diseases: Bibilographic data Diseases listed by decreasing prevalence, incidence or number of published cases

Prevalence and incidence of rare diseases: Bibilographic data Diseases listed by decreasing prevalence, incidence or number of published cases 2 June 2017 Prevalence and incidence of rare diseases: Bibilographic data s listed by decreasing prevalence, incidence or number of published www.orpha.net www.orphadata.org Methodology Orphanet carries

More information

Comprehensive Jewish Carrier Screen

Comprehensive Jewish Carrier Screen Comprehensive Jewish Carrier Screen What is carrier screening? There are several genetic disease mutations that occur at increased frequencies in the Ashkenazi Jewish (Central & Eastern European), Sephardi

More information

Present State of Gene Diagnosis and Future Prospects

Present State of Gene Diagnosis and Future Prospects Clinical Medicine: Cancer Present State of Gene Diagnosis and Future Prospects JMAJ 45(3): 118 124, 2002 Eiichi TAHARA Chairman, Hiroshima Cancer Seminar Foundation Abstract: The entire base sequence of

More information

Newborn bloodspot testing

Newborn bloodspot testing Policy HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited RACP, 145 Macquarie Street, Sydney NSW 2000, Australia

More information

Screening Newborns for Congenital Disorders

Screening Newborns for Congenital Disorders Screening Newborns for Congenital Disorders Gary L. Hoffman, BS; Ronald H. Laessig, PhD ABSTRACT The Newborn Screening Laboratory at the Wisconsin State Laboratory of Hygiene (WSLH) tests all newborn babies

More information

PREMATURITY/ESTIMATED GESTATIONAL AGE

PREMATURITY/ESTIMATED GESTATIONAL AGE PREMATURITY/ESTIMATED GESTATIONAL AGE 765.21 < 24 completed weeks of gestation P07.21 Extreme immaturity of newborn, gestational age less than 23 completed weeks P07.22 Extreme immaturity of newborn, gestational

More information

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 106 disease or trait variations are found in this genome

Genome Summary. Sequencing Coverage: Variation Counts: Known Phenotype Summary: 106 disease or trait variations are found in this genome Report Date: August 24, 2016 Software Annotation Version: 8 Genome Summary Name: (unknown) Genome ID: GFG_filtered_unphased_genotypes Sequencing Provider: (unknown) Sequencing Type: (unknown) Sequencing

More information

PRADER WILLI/ANGELMAN

PRADER WILLI/ANGELMAN SALSA MS-MLPA probemix ME028-B2 PRADER WILLI/ANGELMAN Lot B2-0811: As compared to version B1 (lot B1-0609, B1-1108), the 88 and 96 nt control fragments have been replaced (QDX2). PRADER-WILLI SYNDROME

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 8: Pediatric ESRD 1,462 children in the United States began end-stage renal disease (ESRD) care in 2013. 9,921 children were being treated for ESRD on December

More information

EMBRYO DONOR FAMILY INFORMATION

EMBRYO DONOR FAMILY INFORMATION EMBRYO DONOR FAMILY INFORMATION Please type or use black ink for the information on this sheet so the adoptive family may have some insight into the background of the child that may result from your frozen

More information

CONV. TYPE Unspecified pervasive developmental disorder YES NO Approx. F84.9 Pervasive developmental disorder, unspecified YES YES 307.

CONV. TYPE Unspecified pervasive developmental disorder YES NO Approx. F84.9 Pervasive developmental disorder, unspecified YES YES 307. to Conversion Table Billing Code: Billable ICD-9/ -CM code that can be used to indicate a diagnosis for reimbursement purpose Eligibility Code: ICD-9/ associated with diagnosed conditions with a high probability

More information

Medical Necessity Guidelines: Genetic and Molecular Diagnostic Testing

Medical Necessity Guidelines: Genetic and Molecular Diagnostic Testing Medical Necessity Guidelines: Genetic and Molecular Diagnostic Testing Effective: October 1, 2017 Clinical Documentation and Prior Authorization Required Applies to: Coverage Guideline, No Prior Authorization

More information